Tissue collection

PaCE: Evaluating molecular biomarkers to risk stratify pancreatic cystic lesions



Precision-Panc: Advancing personalised medicine treatment strategies for pancreatic cancer

Learn More


PORTICO-Trans: A feasibility study looking at the immune system in tumours, comparing samples collected during surgery to those taken afterwards

Learn More


Locally advanced

SCALOP2: A multi-centre randomised study of induction chemotherapy followed by capecitabine ( /- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer

Learn More


Metastatic - 1st line

PRIMUS-001: An adaptive phase II study of FOLFOX-A (FOLFOX and nab-paclitaxel) versus AG (nab-paclitaxel and gemcitabine) in patients with metastatic pancreatic cancer, with integrated biomarker evaluation

Learn More


Metastatic - 2nd line and beyond

ATRiUM: A Phase I clinical trial looking at AZD6738 (ATR inhibitor) in combination with Gemcitabine

Learn More